Bambuser AB
STOCKHOLM, SE / ACCESSWIRE / December 21, 2021 / Bambuser AB (STO:BUSER.ST)(FRA:5JL.F)
The board of directors of Bambuser AB ("Bambuser" or the "Company") has today resolved, pursuant to the authorization granted by the annual general meeting on 29 April 2021, to issue 3,246,481 warrants in order to hedge for cash flow impacts of social costs that arises in relation to outstanding employee warrant programs.
The warrants shall be subscribed for, with deviation from the shareholders' preferential rights, by the Company's subsidiary Bambuser Incentive AB. The warrants are issued at no consideration and each warrant entitles to subscription of one share in the Company during the period 1 September 2023 up and including 31 October 2023 at a subscription price corresponding to the quota value of the share (the current quota value is SEK 0.05). If all warrants are utilized for subscription of shares in the Company, it will result in an increase in the Company's share capital of SEK 162,324.05.
The purpose with the issuance and the reason for the deviation from the shareholders' preferential rights is that the issuance shall be directed to the Company's subsidiary Bambuser Incentive AB in order to hedge for the cash flow impacts of social costs that arises in relation to the employee warrant programs resolved upon at the general meetings held on 3 July 2020 and 13 July 2020, respectively. This hedge will not have any effect on the Bambuser Group earnings. The Company's overall assessment is, thus, that the reasons for carrying out the issuance with deviation from the shareholders' preferential rights outweigh the reasons that justify the main rule that new issuances shall be carried out with preferential rights for the shareholders and that the new issuance deviating from the shareholders' preferential rights is in the Company's and all shareholders' interest.
A new share subscribed for by exercise of a warrant has a right to dividends as of the first record day for dividends following registration of the new share issue with the Swedish Companies Registration Office (Sw. Bolagsverket) and after the share has been registered in the share register maintained by Euroclear Sweden AB.
Responsible persons
The information in this press release has been made public by the responsible person below for publication at the time specified by Bambuser's news agency by publication of this press release. The contact person set out below can be contacted for further information.
For further information, please contact:
Maryam Ghahremani, CEO | +46 8 400 160 02 | ir@bambuser.com
Contact information
Corporate Communications, Bambuser AB | +46 8 400 160 00 | ir@bambuser.com
Certified Adviser
Erik Penser Bank AB | +46 8 463 83 00 | certifiedadviser@penser.se
About Bambuser
Bambuser is a software company specializing in interactive live video streaming. The Company's primary product, Live Video Shopping, is a cloud-based software solution that is used by customers such as global e-commerce and retail businesses to host live shopping experiences on websites, mobile apps and social media. Bambuser was founded in 2007 and has its headquarters in Stockholm.
SOURCE: Bambuser AB
View source version on accesswire.com:
https://www.accesswire.com/678993/Bambuser-Issues-3246481-Warrants-in-Order-to-Hedge-for-Cash-Flow-Impacts-of-Social-Costs-in-Relation-to-Outstanding-Employee-Warrant-Programs
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
eComplete Partners with Sourceful to build AI-Native Creative Operations Across Portfolio18.11.2025 15:00:00 CET | Press release
MANCHESTER, UK / ACCESS Newswire / November 18, 2025 / eComplete, the private equity firm behind Current Body's £300 million London Stock Exchange listing, has announced a strategic partnership with Sourceful, the Manchester-based technology company whose Riverflow 1 model ranks as the world's leading AI image editing model. The partnership brings Sourceful's AI-native creative platform to eComplete's portfolio of direct-to-consumer brands, enabling them to generate brand-accurate, production-ready creative assets at scale across e-commerce, social, marketplace and retail. This makes eComplete the first major private equity investor to adopt AI-native creative infrastructure as a core operational advantage. Why this matters Every consumer brand today faces the same constraint: producing thousands of creative assets, product images, ads, videos, packaging, that feel authentically on-brand across every channel and market. This challenge has intensified dramatically over the past three ye
IXOPAY Appoints George Hansen as Chief Revenue Officer to Accelerate Global Growth in Tokenization, Orchestration, and Compliance18.11.2025 06:00:00 CET | Press release
Seasoned payments executive joins IXOPAY to lead global revenue strategy amid rapid growth and the rise of agentic commerce. LEHI, UTAH / ACCESS Newswire / November 18, 2025 / IXOPAY, a global leader in enterprise-grade payment orchestration, today announced the appointment of George Hansen as Chief Revenue Officer (CRO). A veteran of the payments and fintech industries, Hansen brings more than two decades of leadership experience driving growth, transformation, and customer-centric innovation at a global scale. In his new role, Hansen will drive IXOPAY's global revenue strategy, leading sales and partnerships and aligning with marketing and customer success to support enterprise merchants and partners worldwide. His appointment reinforces IXOPAY's commitment to giving merchants full control of their payment strategy through a vendor-neutral architecture designed for scale, flexibility, and intelligence. Hansen has held senior leadership positions at companies including American Expres
General Holdings Limited and NewOak Capital Form Strategic Joint Venture to Launch CMXG, an $800M Commodities Investment Platform18.11.2025 06:00:00 CET | Press release
DUBAI, AE / ACCESS Newswire / November 18, 2025 / General Holdings Limited (GH), a Dubai International Financial Centre-based multi-strategy private investment holding company, and NewOak Capital LLC, a New York collateralized private debt asset management and structured financing and capital markets firm, today announced the formation of Common Commodities CMXG (CMXG), a vertically integrated tech-enabled commodities investment platform designed to deliver risk-controlled, scalable institutional commodity-linked real yield and growth equity to qualified global investors. The partnership combines General Holdings' strategic capital and governance expertise with NewOak Capital's structured asset-based supply-chain financing capabilities and distribution platform. This sets the foundation for "a globally scalable, integrated and transparent institutional trade finance platform facilitating sustainable and inclusive cross-regional growth." Strategic Capital Deployment and Fund Launch CMXG
OBI-902 Has Been Granted by US FDA for Orphan Drug Designation for the Treatment of Cholangiocarcinoma17.11.2025 13:00:00 CET | Press release
OBI-902 is the first ADC utilizing OBI's proprietary GlycOBI® glycan-based ADC enabling technology for evaluation of safety and efficacy in patients with Cancer. TAIPEI, TW / ACCESS Newswire / November 17, 2025 / OBI Pharma, a clinical-stage oncology company (4174.TWO) received notification from the US FDA stating that the request for Orphan Drug Designation of OBI-902 TROP2 ADC for the treatment of Cholangiocarcinoma has been granted. OBI-902 is the first OBI-developed ADC that incorporates our proprietary site-specific glycan-conjugated ADC enabling technology. Cholangiocarcinoma is a rare and lethal malignancy with fewer than 50,000 patients in the United States and a 5-year survival rate ranging from 2% and 23% depending on disease stage, histological subtype, and localization 1 . At present, there are no FDA approved ADC therapies for cholangiocarcinoma. To encourage the industry to develop new treatment options for rare diseases, the US FDA grants Orphan Drug Designation to exper
Camino Completes C$5.6 Million Investment with Strategic Investors17.11.2025 12:00:00 CET | Press release
VANCOUVER, BC / ACCESS Newswire / November 17, 2025 / Camino Minerals Corporation (TSXV:COR)(OTC:CAMZF) ("Camino" or the "Company") is pleased to announce the closing of its -brokered private placement (the "Financing") of common shares in the capital of the Company (the "Shares") previously announced in its news release dated November 12, 2025. Under the Financing, the Company issued an aggregate of 15,554,666 Shares at an issue price of $0.36 per Share, for aggregate gross proceeds of C$5,599,680. Participants in the Financing included two new key shareholders, Elemental Royalties (formerly EMX Royalty Corp.) and Continental General Insurance Company, as well as certain insiders of Camino. The gross proceeds of the Financing will be applied towards corporate working capital, legal expenses, engineering studies, project development, and general administrative expenses. The Shares issued pursuant to the Financing are subject to a statutory hold period expiring on March 15, 2026, in acc
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom